Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs
- PMID: 12428908
- DOI: 10.1023/a:1020198908574
Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs
Abstract
The induction of effective cellular and humoral immune responses against protein antigens is of major importance in vaccination strategies against infectious diseases and cancer. Immunization with protein alone in general does not result in efficient induction of cytotoxic T lymphocyte (CTL) and antibody responses. Numerous other immunization strategies have been explored. In this review we will discuss a number of lipid-based antigen delivery systems suitable for the induction of CTL responses. These systems comprise reconstituted virus envelopes (virosomes), liposomes, and immune-stimulating complexes (ISCOMs). We will concentrate on delivery of the protein antigen ovalbumin (OVA) since extensive studies with this antigen have been performed for all of the systems discussed, allowing direct comparison of antigen delivery efficiency. Stimulation of CTL activity requires processing of the antigen in the cytosol of antigen-presenting cells (APCs) and presentation of antigenic peptides on surface major histocompatibility class I complexes (MHC class I). In vitro, the ability of antigen delivery systems to induce MHC class I presentation indeed correlates with their capacity to deliver antigen to the cytosol of cells. This capacity appears to be less important for the induction of cytotoxic T lymphocytes in vivo. Instead, other properties of the antigen delivery system like activation of APCs and induction of T helper cells play a more prominent role. Fusion-active virosomes appear to be a very potent system for induction of CTL activity, most likely since virosomes combine efficient delivery of antigen with general stimulation of the immune system.
Similar articles
-
Virosomes for antigen and DNA delivery.Adv Drug Deliv Rev. 2005 Jan 10;57(3):451-63. doi: 10.1016/j.addr.2004.09.005. Adv Drug Deliv Rev. 2005. PMID: 15560951 Review.
-
Virosome-mediated delivery of protein antigens to dendritic cells.Vaccine. 2002 May 22;20(17-18):2287-95. doi: 10.1016/s0264-410x(02)00103-2. Vaccine. 2002. PMID: 12009284
-
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.Vaccine. 2005 Jan 26;23(10):1232-41. doi: 10.1016/j.vaccine.2004.09.002. Vaccine. 2005. PMID: 15652665
-
Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes.Vaccine. 2000 Jan 31;18(14):1327-33. doi: 10.1016/s0264-410x(99)00404-1. Vaccine. 2000. PMID: 10618529
-
Liposomal delivery of CTL epitopes to dendritic cells.Biosci Rep. 2002 Apr;22(2):339-53. doi: 10.1023/a:1020151025412. Biosci Rep. 2002. PMID: 12428909 Review.
Cited by
-
Conference report--adjuvants and delivery: improving on vaccine immunogenicity highlights from the viral vaccine meeting; October 25-28, 2003; Barcelona, Spain.MedGenMed. 2004 Jan 26;6(1):46. MedGenMed. 2004. PMID: 15208557 Free PMC article.
-
Advanced antigen delivery of murine survivin: chimeric virus-like particles in cancer vaccine research.Int J Biomed Sci. 2007 Sep;3(3):199-205. Int J Biomed Sci. 2007. PMID: 23675044 Free PMC article.
-
Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen.Front Immunol. 2017 Apr 7;8:359. doi: 10.3389/fimmu.2017.00359. eCollection 2017. Front Immunol. 2017. PMID: 28439267 Free PMC article.
-
Cell penetrating peptide: A potent delivery system in vaccine development.Front Pharmacol. 2022 Nov 8;13:1072685. doi: 10.3389/fphar.2022.1072685. eCollection 2022. Front Pharmacol. 2022. PMID: 36425579 Free PMC article. Review.
-
Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery.ISRN Pharm. 2012;2012:474830. doi: 10.5402/2012/474830. Epub 2012 Jul 19. ISRN Pharm. 2012. PMID: 22888455 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous